China-based WuXi AppTec wins $19M from taxpayers for giant Delaware drug plant Joseph N. DiStefano, The Philadelphia Inquirer
WuXi AppTec, a Chinese-owned pharma company that already runs Philadelphia’s largest cell and gene therapy factory, on Monday was awarded $19 million in state investment and job training grants to build “Project Dragonfly,” a much larger pill factory, with labs and offices, on farmland in northern Delaware.
Popular Searches
WuXi will decide by mid-July whether it will choose the 190-acre site in the industrial boom town of Middletown, west of Wilmington and about 20 miles south of the Pennsylvania state line, according to Dean Childers, a veteran pharmaceuticals executive who will head the new plant. The company hopes to hear before then about an additional $2 million state grant to improve roads on the site. The firm would not disclose the location of a second site under consideration.
Shanghai
China
United-states
Wuxi
Jiangsu
New-jersey
New-castle-county
Delaware
Middletown
Pennsylvania
Philadelphia
University-of-pennsylvania